Revolutionary CRISPR Gene Editing Technique Offers Hope for Genetic Disease Treatment

Introduction to CRISPR-SKIP

Potential for Biomedical Applications

A recent study published in *Genome Biology* highlights the significant potential of CRISPR-SKIP, a novel gene editing method. This advancement brings us closer to the possibility of treating previously incurable genetic diseases caused by genetic errors or mutations.

Research Background

Conducted by scientists at the University of Illinois, this research builds on the foundational work of the CRISPR-Cas9 genome editing system. Traditionally, cells interpret DNA to produce essential proteins for various biological functions. By utilizing CRISPR technology, researchers can modify how DNA is read, enhancing possibilities for genetic interventions.

Understanding CRISPR-SKIP

Mechanism of Action

Unlike conventional CRISPR-Cas9, which typically cuts DNA to remove faulty genes, CRISPR-SKIP introduces a modification to a single base of the targeted DNA sequence. This alteration causes the cell to skip the problematic section of DNA, effectively bypassing the mutations.

Implications for Genetic Diseases

The authors of the study assert that CRISPR-SKIP can permanently eliminate faulty DNA segments, offering a long-lasting treatment solution for certain genetic disorders with just one application. Initial tests have shown success in cell lines derived from both mice and humans, with future plans to evaluate the technique in live organisms.

Broader Applications of CRISPR-SKIP

Potential Diseases Targeted

CRISPR-SKIP may hold promise for addressing a variety of diseases, including cancer, rheumatoid arthritis, Huntington’s disease, and Duchenne muscular dystrophy. Its ability to edit a single base makes it a straightforward, precise, and versatile approach applicable to numerous cell types and therapeutic contexts.

Conclusion

The ongoing research into CRISPR-SKIP represents a significant leap forward in gene editing, paving the way for innovative treatments for genetic diseases.

Author Information

Written by Cindi A. Hoover, Ph.D.

References

Gapinske et al. CRISPR-SKIP: programmable gene splicing with single base editors. 2018. *Genome Biology* 19:107.
New CRISPR technique that skips over portions of genes that can cause disease. https://news.illinois.edu/view/6367/683492